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A B S T R A C T
Background
People with active tuberculosis (TB) require six months of treatment. Some people find it difficult to complete treatment, and there
are several approaches to help ensure completion. One such system relies on reminders, where the health system prompts patients to
attend for appointments on time, or re-engages people who have missed or defaulted on a scheduled appointment.
Objectives
To assess the effects of reminder systems on improving attendance at TB diagnosis, prophylaxis, and treatment clinic appointments,
and their effects on TB treatment outcomes.
Search methods
We searched the Cochrane Infectious Diseases Group Specialized Register, Cochrane Effective Practice and Organization of Care Group
Specialized Register, CENTRAL,MEDLINE, EMBASE, LILACS, CINAHL, SCI-EXPANDED, SSCI,mRCT, and the Indian Journal
of Tuberculosis without language restriction up to 29 August 2014. We also checked reference lists and contacted researchers working
in the field.
Selection criteria
Randomized controlled trials (RCTs), including cluster RCTs and quasi-RCTs, and controlled before-and-after studies comparing
reminder systems with no reminders or an alternative reminder system for people with scheduled appointments for TB diagnosis,
prophylaxis, or treatment.
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Data collection and analysis
Two review authors independently extracted data and assessed the risk of bias in the included trials. We compared the effects of
interventions by using risk ratios (RR) and presented RRs with 95% confidence intervals (CIs). Also we assessed the quality of evidence
using the GRADE approach.
Main results
Nine trials, including 4654 participants, met our inclusion criteria. Five trials evaluated appointment reminders for people on treatment
for active TB, two for people on prophylaxis for latent TB, and four for people undergoing TB screening using skin tests. We classified
the interventions into ’pre-appointment’ reminders (telephone calls or letters prior to a scheduled appointment) or ’default’ reminders
(telephone calls, letters, or home visits to people who had missed an appointment).
For people being treated for active TB, clinic attendance and TB treatment completion were higher in people receiving pre-appointment
reminder phone-calls (clinic attendance: 66% versus 50%; RR 1.32, 95% CI 1.10 to 1.59, one trial (USA), 615 participants, low
quality evidence; TB treatment completion: 100% versus 88%; RR 1.14, 95% CI 1.02 to 1.27, one trial (Thailand), 92 participants,
low quality evidence). Clinic attendance and TB treatment completion were also higher with default reminders (letters or home visits)
(clinic attendance: 52% versus 10%; RR 5.04, 95% CI 1.61 to 15.78, one trial (India), 52 participants, low quality evidence; treatment
completion: RR 1.17, 95% CI 1.11 to 1.24, two trials (Iraq and India), 680 participants, moderate quality evidence).
For people on TB prophylaxis, clinic attendance was higher with a policy of pre-appointment phone-calls (63% versus 48%; RR 1.30,
95% CI 1.07 to 1.59, one trial (USA), 536 participants); and attendance at the final clinic was higher with regular three-monthly
phone-calls or nurse visits (93% versus 65%, one trial (Spain), 318 participants).
For people undergoing screening for TB, three trials of pre-appointment phone-calls found little or no effect on the proportion of
people returning to clinic for the result of their skin test (three trials, 1189 participants, low quality evidence), and two trials found little
or no effect with take home reminder cards (two trials, 711 participants). All four trials were conducted among healthy volunteers in
the USA.
Authors’ conclusions
Policies of sending reminders to people pre-appointment, and contacting people who miss appointments, seem sensible additions to
any TB programme, and the limited evidence available suggests they have small but potentially important benefits. Future studies of
modern technologies such as short message service (SMS) reminders would be useful, particularly in low-resource settings.
P L A I N L A N G U A G E S U M M A R Y
Reminder systems to improve patient attendance at tuberculosis clinics
This Cochrane Review summarizes trials evaluating the effects of reminder systems on attendance at tuberculosis (TB) clinics and
completion of TB treatment. After searching for relevant trials up to 29 August 2014, we included nine trials, including 4654 people.
What are reminder systems and how might they help?
Effective treatment for TB requires people to take multiple drugs daily for at least six months. Consequently, once they start to feel well
again, some patients stop attending clinics and stop taking their medication which can lead to the illness returning and the development
of drug resistance. One strategy theWorld Health Organization recommends is that an appointed person (a health worker or volunteer)
watches the person take their medication everyday (called direct observation). Other strategies include reminder systems to prompt
patients to attend for appointments on time, or to re-engage people who have missed or defaulted on a scheduled appointment. These
prompts may be in the form of telephone calls or letters before the next scheduled appointment (“pre-appointment reminders”), or
phone calls, letters, or home visits after a missed appointment (“default reminders”).
What the research says:
For people being treated for active TB:
- More people attended the clinic and completed TB treatment with pre-appointment reminder phone-calls (low quality evidence).
- More people attended the clinic and completed TB treatment with a policy of default reminders (low and moderate quality evidence
respectively).
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For people on TB prophylaxis:
- More people attended the clinic with pre-appointment phone-calls, and the number attending the final clinic was higher with three-
monthly phone-calls or nurse home visits.
For people undergoing screening for TB:
- Similar numbers of people attended clinic for skin test reading with and without pre-appointment phone-calls (low quality evidence).
- Similar numbers of people attended clinic for skin test reading with and without take home reminder cards.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
TB treatment: pre-appointment reminder versus no reminder
Patient or population: People on TB treatment
Settings: Outpatient clinic
Intervention: Pre-appointment reminder
Comparison: No reminder
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
No reminder Pre-appointment reminder
Attendance at single clinic
appointment
50 per 100 66 per 100
(55 to 80)
RR 1.32
(1.10 to 1.59)
615
(1 trial)
⊕⊕©©
low1,2
Completion of TB treatment 88 per 100 100 per 100
(90 to 100)
RR 1.14
(1.02 to 1.27)
92
(1 trial)
⊕⊕©©
low3,4,5
The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded by 1 for serious risk of bias: This trial was quasi-randomized and is at high risk of selection bias.
2Downgraded by 1 for serious indirectness: Clinic attendance in this single trial from the USA is very low. It is unclear whether DOTS
was implemented at the trial site, and the findings may not be easily generalizable elsewhere
3Downgraded by 1 for serious risk of bias: No details of randomization are provided and the risk of selection bias.
4Downgraded by 1 for serious imprecision: This trial is very underpowered to detect this effect.
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5No serious indirectness: This is a single trial of pre-appointment phone call reminders in adults from Thailand where DOTS was being
implemented. Although its findings may not be easily generalized to all settings, it is likely to be similar to TB-endemic settings in
developing countries.
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B A C K G R O U N D
Description of the condition
Tuberculosis (TB) is caused by infection with Mycobacterium tu-
berculosis, and spreads from person to person through inhalation
of droplets nuclei. As a cause of human suffering, death, and im-
poverishment, TB ranks among the leading infectious diseases. In
2012, there were an estimated 8.6 million incident cases of TB
and 1.3 million TB-related deaths worldwide (WHO 2013).
In some settings, groups of people considered to be at high risk
may be screened for latent TB infection using Purified Protein
Derivative (PPD) tests (also known as tuberculin skin tests), such
as the Mantoux or Heaf tests, or the more recently developed in-
terferon-gamma blood tests. PPD tests involve injecting a protein
derivative of the M. tuberculosis bacillus into the skin, waiting 48
to 72 hours, and thenmeasuring any localized swelling (or indura-
tion) of the skin around the injection site. People with positive
results may then undergo further tests to detect or exclude active
TB. Latent TB is treated for up to 12months with antituberculous
drugs to clear the latent infection and prevent the development of
active disease; termed ’TB prophylaxis’.
The standard method for diagnosing active pulmonary TB (PTB)
is sputum microscopy and culture, where people provide two or
three sputum samples, including an early morning sample, col-
lected on separate occasions. Patients are advised to return to the
clinic to receive the results, and those with positive results are then
referred for treatment.More recently, theWorldHealthOrganiza-
tion (WHO) has also recommended the use of a rapid molecular
diagnostic test, known as Xpert® MTB/RIF, which can provide
results within two hours (WHO 2011;Steingart 2014).
Treatment for active TB requires patients to take multiple med-
ications for at least six months. The standard regimen currently
recommended by the WHO includes four drugs for two months
(the intensive phase), followed by two drugs for four months (the
consolidation phase) (WHO 2003a).
Poor adherence to antituberculous treatment may lead to treat-
ment failure and relapse (Ormerod 1991), drug resistance (Weis
1994;Mitchison 1998), and prolonged and expensive therapy that
is less likely to be successful than the treatment of drug-susceptible
TB (Goble 1993). Poor adherence also results in increased trans-
mission rates of the tubercle bacilli, morbidity, and cost to the TB
control programmes (Johansson 1999).
Description of the intervention
Adherence to a TB diagnosis and treatment programme requires
accessible and appropriate health care, and a number of interven-
tions have been used to promote adherence (WHO 2003b). Di-
rectly observed therapy (DOT), where an appointed agent (health
worker, community volunteer, or family member) watches the pa-
tient swallow their medication each day, has been the mainstay
of adherence promotion since its introduction in the 1990s, and
the randomized evidence of its effects is summarized in a previous
systematic review (Volmink 2007).
Reminder systems are policies implemented by the health service
to improve or maintain attendance at appointments or adherence
to treatment. The remindersmay consist of home visits to patients,
letters, telephone calls, e-mails or short message service (SMS) text
messages (Thilakavathi 1993; Green 2003), and may be under-
taken by health service staff, volunteers, or community members.
They may sometimes include a health education component; ex-
plaining to the patient the benefits of attending appointments and
taking medication. In this review we classify the reminder systems
into:
• Pre-appointment reminders; defined as any action to
contact patients shortly before they are due to take their
medication or attend a healthcare appointment, and remind
them to take their medication or attend their appointment, and
• Default reminders (sometimes called ’defaulter actions’ or
’late patient tracers’); defined as actions undertaken when a
patient fails to keep an appointment. They generally aim to re-
establish contact with the patient, to find out why they did not
attend, and to encourage re-engagement with services.
This Cochrane Review is one of several published, planned, or in
progress to evaluate different strategies to promote adherence:
• Reminder systems to improve patient adherence to TB
clinic appointments for diagnosis and treatment: reminding
patients to keep an appointment and actions taken when patients
fail to keep an appointment (this review).
• DOT: an appointed agent (health worker, community
volunteer, family member) directly monitors people swallowing
their antituberculous drugs (Volmink 2007). (This is one of the
five components of the wider strategy called ’DOTS’ (the
directly observed treatment, short course), which remains at the
heart of global Stop TB Strategy (WHO 2006)).
• Patient education and counselling for promoting adherence
to treatment for TB: provision of information or one-to-one or
group counselling about TB and the need to complete treatment
(M’Imunya 2012).
• Material incentives and enablers in the management of TB:
cash or vouchers for patients to promote their return for the
results of tests or to take prescribed treatments (Lutge 2012).
• Staff motivation and supervision: training and management
processes that aim to improve how providers care for people with
TB.
• Peer assistance: people from the same social group helping
someone with TB return to the health service by prompting or
accompanying them.
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How the intervention might work
Reminders are not newly developed interventions, and some na-
tional treatment programmes use one or both types of reminders
as standard procedure. For example, in South Africa, the TB con-
trol programme uses a client-held card and a clinic card where the
next appointment is recorded, which serve as a pre-appointment
reminder to both the patients and the health workers (National
Department of Health South Africa 2014). In 1988 to 1989, the
national treatment programme manuals in India recommended
defaulter reminders to contact patients who did not return to the
clinic for their fortnightly drug collection, on the first day after a
missed appointment and then on the fourth day (Jagota 1996). In
Malaysia, where DOT is used, when patients have missed more
than seven consecutive days of treatment, a specialist tracing team
visits their home to find out why they have not attended the clinic
for treatment. Another visit is made if the patient subsequently
fails to attend (O’Boyle 2002).
Due to increasingMDR-TB prevalence inmany countries, actions
to remind patients about attending clinic appointments for diag-
nosis and treatment play an important role in preventing multi-
drug resistance to anti-TB drugs. In this review, we look at the
effects of reminders in two aspects: (1) whether a single reminder
action has any potential efficacy on attendance at the next TB
clinic appointment; and (2) whether a policy of regularly remind-
ing patients who missed their appointments could improve their
outcomes including TB cure or treatment completion.
Why it is important to do this review
Reminder systems as strategies to improve patients’ adherence to
TB screening, diagnosis, and treatment have not been reviewed
systematically before. This Cochrane Review seeks to fill the gap
in evidence, and highlight where more research might be needed.
O B J E C T I V E S
To assess the effects of reminder systems on improving attendance
at TB diagnosis, prophylaxis, and treatment clinic appointments,
and their effects on TB treatment outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
• Randomized controlled trials (RCTs) including cluster
RCTs and quasi-RCTs.
• Controlled before-and-after studies (CBAs).
Types of participants
• Children and adults in any setting who require treatment
for TB. This includes people with PTB (diagnosed by sputum
microscopy, culture, or both, regardless of HIV status), smear-
negative PTB (diagnosed by symptoms and chest radiograph
findings, or other diagnostic tests, regardless of HIV status), or
extrapulmonary TB (diagnosed by signs or symptoms and
histopathology, sputum acid-fast bacilli smear, culture, or both,
imaging studies or polymerase chain reaction (PCR)).
• Children and adults in any setting with TB infection who
require prophylaxis against TB.
• Children and adults in any setting referred (including self-
referred) to TB diagnostic or screening services.
Types of interventions
Interventions
• Any actions taken to remind patients to take their TB
medication or attend appointments (pre-appointment
reminders).
• Any actions to contact patients who have missed an
appointment (default reminders).
Controls
• No reminders.
• Other kinds of reminder actions or other interventions to
improve adherence.
Types of outcome measures
Primary outcomes
• Completion of TB diagnostics.
• Completion of screening process.
• Commencement of prophylactic treatment.
• Commencement of curative treatment.
• Completion of prophylactic treatment.
• Completion of curative treatment.
• Cure.
• Incidence of active TB (in studies of prophylactic
treatment).
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Secondary outcomes
• Any measure of adherence to treatment or attendance at
appointments.
• Any measure of patient involvement or patient satisfaction.
• Any adverse event (for example, elevated liver enzymes,
optic neuritis).
Search methods for identification of studies
We attempted to identify all relevant studies regardless of language
or publication status (published, unpublished, in press, and in
progress).
Databases
We searched the following databases using the search terms and
strategy described in Table 1: Cochrane Infectious Diseases Group
Specialized Register (29 August 2014); Cochrane Effective Prac-
tice and Organization of Care Group Specialized Register (29 Au-
gust 2014); CochraneCentral Register of ControlledTrials (CEN-
TRAL), published inThe Cochrane Library (2014, Issue 8);MED-
LINE (1966 to 29 August 2014); EMBASE (1974 to 29 Au-
gust 2014); LILACS (1982 to 29 August 2014); CINAHL (1982
to 29 August 2014); Science Citation Index Expanded (SCI-EX-
PANDED; 1945 to 29 August 2014); and the Social Sciences Ci-
tation Index (SSCI; 1956 to 29 August 2014). We also searched
the metaRegister of Controlled Trials (mRCT) using the terms:
’tuberculosis’ and ’(reminder OR compliance)’ (29 August 2014).
Researchers and organizations
For unpublished and ongoing trials, we contacted study authors
andother researchersworking in the field and the followingorgani-
zations: WHO; the Tuberculosis Trials Consortium (TBTC); the
International Union against TB and Lung Diseases (IUATLD);
the European Developing Countries Clinical Trials Programme
(EDCTP); and the Global Partnership to Stop TB.
Non-indexed journals
We searched the online Indian Journal of Tuberculosis from 1983
to 29 August 2014 using ’tuberculosis’ and ’(reminder OR com-
pliance)’ as search terms.
Reference lists
We also checked the reference lists of all studies identified by the
above methods.
Data collection and analysis
Selection of studies
KA and MAL independently applied the inclusion criteria to all
identified trials, and screened all citations and abstracts identified
by the search strategy to exclude trials that clearly did not meet
the inclusion criteria. If either review author judged that the trial
might be eligible for inclusion, we obtained the full paper. After
obtaining full reports of all potentially eligible studies, KA and
QL assessed these for inclusion in the review using a pre-designed
eligibility form based on the inclusion criteria and resolved any
disagreements by discussion with a third author (MAL). We also
scrutinized publications to ensure that each trial was included
only once. We excluded studies that did not meet the inclusion
criteria and documented the reasons for exclusion in the table of
’Characteristics of excluded studies’.
Data extraction and management
MA and VB independently extracted the data using a tailored
data extraction form. We extracted data on trial design, methods,
participant characteristics, interventions, and outcomes. For di-
chotomous data, we extracted the number of events of interest,
the total number randomized to each group, and the total num-
ber analysed. For continuous data, we extracted the number of
participants randomized, the number analysed, and the number
of participants in each group; and also the arithmetic means and
their standard deviations for some variables. We contacted trial
authors to obtain missing information and to clarify issues. We
resolved discrepancies by discussion with a third author (QL).
Assessment of risk of bias in included studies
MA and VB independently assessed the risk of bias in each in-
cluded trial using the Cochrane Collaboration’s tool for assessing
the risk of bias (Higgins 2011). For RCTs and quasi-RCTs, we
assessed the random sequence generation, allocation concealment,
blinding of outcome assessment, incomplete outcome data, selec-
tive outcome reporting, and ’other bias’. For each included trial,
the two review authors independently described the procedures
that the trial authors reported for each domain and then made a
decision relating to the risk of bias for that domain by assigning a
judgement of ’low risk’ of bias, ’high risk’ of bias, or ’unclear risk’
of bias. We also contacted the trial authors when essential informa-
tion to judge quality was missing. We resolved any disagreements
by discussion and by consulting a third review author (QL) when
necessary.
Measures of treatment effect
We calculated risk ratios (RRs) with 95% confidence intervals (CI)
for dichotomous data.
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Unit of analysis issues
We did not include any cluster-RCTs in our review, so the intr-
acluster correlation coefficients (ICC) estimates were inappropri-
ate.
Dealing with missing data
In order to appropriately describe the trial results, we contacted
the trial authors to request missing data. We presented the results
of the trials individually using an available-case analysis.
Assessment of heterogeneity
We tested for heterogeneity using the Chi2 test for heterogeneity
with a cut-off of P < 0.10 and the I2 statistic, with > 50% indicating
statistical significant heterogeneity.
Assessment of reporting biases
Statistical assessment of potential publication bias was not possible
given the small number of eligible trials.
Data synthesis
QL undertook the analyses using Review Manager 5 in consul-
tation with the other review authors. All trials reported only di-
chotomous data, sowe have expressed trial results as risk ratio (RR)
with its 95% CIs for each outcome. When significant statistical
heterogeneity was present and it was appropriate to combine the
data, we used the random-effects model. We stratified the analy-
sis by the type of reminder (pre-appointment reminders, default
reminders), and trial design. For future updates, we will use the
methods outlined in the protocol to handle other types of data that
may become available (for example, continuous data, or analysis
of cluster trials, or controlled before-and-after studies).
We used the GRADE approach to assess and grade the quality of
evidence of primary outcomes. The quality rating across studies
has four levels: high, moderate, low, or very low. RCTs are initially
categorized as high quality but can be downgraded after assessment
of five criteria: risk of bias, consistency, directness, imprecision,
and publication bias (Guyatt 2008).
Subgroup analysis and investigation of heterogeneity
We had planned to perform subgroup analysis, with subgroups
defined by the participant age (adults or children), sex, setting
(for example, rural or urban, high- or low-income country), spe-
cial populations (people with HIV/AIDS, intravenous drug users,
refugees, asylum seekers, homeless people, and alcoholics), type of
reminder (for example, letters, telephone calls, home visits, type of
person contacting the patient), prophylactic or curative treatment,
new cases or those who have previously interrupted treatment,
method of diagnosis used, and type of treatment programme (for
example, DOT, or mainly self-administered). However, due to the
small number of trials included in the review, we could not inves-
tigate heterogeneity using subgroups as previously planned.
Sensitivity analysis
We conducted a sensitivity analysis excluding trials with high risk
of bias to investigate the robustness of the results to the various
risk of bias components.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies; and Table 2.
Results of the search
Figure 1 shows the summary of the trial selection process.
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Figure 1. Study flow diagram.
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We obtained 1012 titles and abstracts after removal of du-
plicates from the electronic search of databases, and no addi-
tional articles from contacting researchers or screening reference
lists. We judged 41 articles as potentially eligible after abstract
screening and assessed the full-text articles for inclusion or ex-
clusion. Seven studies are currently ongoing (CTRI/2011/07/
001889; ISRCTN46846388; NCT01471977; NCT01549457;
NCT01690754; NCT02082340; PACTR201307000583416).
Included studies
Nine trials involving 4654 participants met our inclusion criteria,
of which twowere reported in a single publication (Roberts 1983a;
Roberts 1983b).
Type of intervention
Pre-appointment reminders
Two individually quasi-RCTs (Tanke 1994; Cheng 1997) and
four individually RCTs (Roberts 1983a; Roberts 1983b; Salleras
Sanmarti 1993; Kunawararak 2011) evaluated pre-appointment
reminders.
Roberts 1983a compared eight groups receiving four types of re-
turn reminders, including postcard, telephone call, direct person-
to-person, and take-home card in combination with two types of
authority sources (experts and non-experts). Roberts 1983b com-
pared 12 groups receiving a combination of two types of message
on the importance of returning (enhanced versus standard), two
types of reminders (take-home card versus no reminder card), and
three types of overt commitment to return (verbal, verbal plus
written agreement, or no commitment).
Except for one trial (Kunawararak 2011), all the other trials had
more than one intervention arm. Kunawararak 2011 compared
DOTS plus a daily mobile phone call reminder with DOTS only.
Cheng 1997 applied five types of intervention for following up
the TB test reading, of which the intervention of interest for this
review was the reminder phone call in group 2. Tanke 1994 com-
pared no message with four types of automated telephone re-
minders (basic reminder, basic reminder plus authority endorse-
ment, basic reminder plus importance statement, and basic re-
minder plus importance statement plus authority endorsement)
for patients scheduled for three different clinic appointments.
Salleras Sanmarti 1993 compared three types of intervention with
a control; the interventions in groups one and two (telephone call
reminder and home visit by specialized nursing personnel) met
our inclusion criteria.
Default reminders
Three individually RCTsmet our inclusion criteria (Krishnaswami
1981; Paramasivan 1993; Mohan 2003). Krishnaswami 1981
compared the effectiveness of two kinds of default reminders, a
home visit and if necessary up to another three visits compared
with a reminder letter the first time and if necessary a home visit
once. Paramasivan 1993 and Mohan 2003 compared reminder
letters or routine home visiting for patients missing an appoint-
ment with a control group without reminders. In Mohan 2003,
the home visitors also carried out health education for the patient
and his/her family.
Countries
Most of the trials assessing pre-appointment reminders were car-
ried out in the USA (Roberts 1983a; Roberts 1983b; Tanke
1994; Cheng 1997), except one trial carried out in Spain (Salleras
Sanmarti 1993) and one in Thailand (Kunawararak 2011). Of the
trials assessing default reminders, two were carried out in India
(Krishnaswami 1981; Paramasivan 1993) and one in Iraq (Mohan
2003).
Participants
For pre-appointment reminders:
• One was conducted in new sputum smear positive PTB
patients including both non-MDR-TB and MDR-TB
(Kunawararak 2011).
• One was conducted in primary school children undergoing
TB chemoprophylaxis (Salleras Sanmarti 1993).
• Three trials assessed the effectiveness of different reminders
on the tuberculin skin test return in different trial populations:
Cheng 1997 studied children aged 1 to 12 years; and Roberts
1983a/Roberts 1983b studied college students who were
volunteers in a university-sponsored TB detection drive.
• One was conducted in a wide range of age groups receiving
TB diagnosis, TB chemoprophylaxis, or treatment (Tanke 1994).
For default reminders, all three trials were conducted among pa-
tients undergoing treatment for active TB:
• Krishnaswami 1981 included patients aged 12 years or
more with radiographic evidence of TB but negative smears.
• Paramasivan 1993 studied newly diagnosed adult sputum
smear-positive PTB patients.
• Mohan 2003 studied new smear-positive PTB patients who
delayed coming to collect drugs at the health centre for at least
three days after a scheduled appointment.
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Setting
The six pre-appointment reminder trials were performed in differ-
ent settings, including a children’s national medical centre (Cheng
1997), clinics (Tanke 1994), a public hospital (Kunawararak
2011), a primary school (Salleras Sanmarti 1993), and a univer-
sity (Roberts 1983a; Roberts 1983b). All three default reminder
trials were performed in clinics (Krishnaswami 1981; Paramasivan
1993; Mohan 2003).
Outcomes
The main outcomes assessed in the pre-appointment reminder
trials were the number of patients who adhered to a scheduled
appointment and cure, defined in the protocol; and for default
reminders, the number of patients who completed treatment.
Excluded studies
Twenty-six studies that initially seemed to fit the inclusion crite-
ria were eventually excluded for the reasons given in the table of
Characteristics of excluded studies. The most common reasons for
exclusion were no intervention of interest included and inappro-
priate study design (such as, non-randomized clinical trials).
Risk of bias in included studies
Our assessment of risk of bias is summarized in the Characteristics
of included studies table, Figure 2, and Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included trials.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
trial.
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Allocation
For pre-appointment reminder trials, two trials used a quasi-RCT
design (Tanke 1994; Cheng 1997), and the remaining four tri-
als used a RCT design (Roberts 1983a; Roberts 1983b; Salleras
Sanmarti 1993; Kunawararak 2011). Cheng 1997 allocated by day
of the week; for Tanke 1994, within each five-week period each
message variation was used once on each weekday and different
variations were used each day of a given week by a computer-gen-
erated system. The allocation generation in four RCTs was not
clearly documented. In all the included trials on pre-appointment
reminders, concealment of allocation was not clearly documented.
For default reminders, three trials used a RCT design. In both
Paramasivan 1993 and Mohan 2003, the generation of the allo-
cation sequence and allocation concealment were adequate, while
in Krishnaswami 1981, allocation generation and allocation con-
cealment were not clearly documented.
Blinding
The blinding of outcome assessors was adequate in Mohan 2003,
inadequate in Paramasivan 1993, and unclear in the seven other
trials.
Incomplete outcome data
All the included trials addressed incomplete outcome data ade-
quately, except Salleras Sanmarti 1993, In this trial, 43 out of 318
patients initially enrolled withdrew from the treatment, but the
number withdrawn from each group was not stated, nor the rea-
sons for missing data provided.
Selective reporting
It was unclear if any of the included trials was free of selective
outcome reporting as the trial protocols were not available and no
information on the pre-specified outcomes was given. However,
there was no clear evidence of selective reporting in the included
trials and all of the outcomes specified in the trialsmethods sections
were reported.
Other potential sources of bias
Our assessment indicated that the included trials were free of other
biases.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings table 1; Summary of findings 2 Summary of findings
table 2; Summary of findings 3 Summary of findings table 3
See: Summary of findings for the main comparison, Summary of
findings 2, and Summary of findings 3 for the main comparisons.
TB treatment
Five trials from India (2), Iraq, Thailand, and the USA, evaluated
the effects of reminder policies in people being treated for active
TB. Two implemented a policy of pre-appointment reminders
(Tanke 1994; Kunawararak 2011), two implemented a policy of
reminders for people who had missed an appointment (default
reminders) (Paramasivan 1993; Mohan 2003), and one compared
two different forms of default reminders (Krishnaswami 1981).
Of these, only two trials stated that DOT was currently being
implemented for all patients (Mohan 2003; Kunawararak 2011).
Comparison 1: Reminder versus none
Pre-appointment reminder
In one trial, pre-appointment telephone reminders increased clinic
attendance from 50% to 66% (RR 1.32, 95% CI 1.10 to 1.59,
one trial, 615 participants, Analysis 1.1), and it was unclear how
treatment was supervised.
In one small trial from a setting where DOTS was currently im-
plemented, a policy of pre-appointment telephone reminders in-
creased treatment completion from 88% to 100% (RR 1.14, 95%
CI 1.02 to 1.27, one trial, 98 participants, Analysis 1.2). This trial
provided few details on the process of randomization and is at
unclear risk of selection bias. It is significantly underpowered to
detect this effect (see Table 3).
Default reminder
In one trial, with low rates of clinic attendance, reminder letters
increased clinic attendance from 10% to 52% (RR 5.04, 95% CI
1.61 to 15.78, one trial, 52 participants, Analysis 1.1). In this very
small trial treatment was self-supervised with monthly pick-up
of medications. The findings may not be applicable to situations
where treatment is directly observed.
In two further trials, policies of default reminders increased treat-
ment completion from 73% to 88% in a setting without DOTS,
and from 83% to 96% in a setting where DOTS was implemented
(RR 1.17, 95% CI 1.11 to 1.24, two trials, 680 participants,
Analysis 1.2). In the first trial, volunteers visited people who had
missed an appointment at their own homes to motivate them to
attend and provide health education (Mohan 2003). In the second
trial, letters were sent on the fourth day after a missed appoint-
ment (Paramasivan 1993).
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Comparison 2: Different types of reminder (home visit
versus letter after a missed appointment)
In one additional trial from a setting without DOTS, there were
no statistically significant differences in clinic attendance or treat-
ment completion between a policy of home visits after amissed ap-
pointment and a policy of sending reminder letters to people who
had missed an appointment (one trial, 121 participants, Analysis
2.1; 150 participants, Analysis 2.2). Treatment completion in this
setting was 60% with reminder letters, and 72% with home visits.
TB prophylaxis
Comparison 3: Reminder versus none
Two trials, from the USA and Spain, evaluated reminders for peo-
ple on TB prophylaxis. In the USA, pre-appointment telephone
reminders increased attendance at a single clinic appointment from
48% to 62.5% (RR 1.30, 95% CI 1.07 to 1.59, one trial, 536
participants, Analysis 3.1).
In Spain, where children were given 12 months of isoniazid treat-
ment to be supervised at home by their parents, attendance at the
final clinic appointmentwas increased by a policy of routine phone
calls every three months (RR 1.44, 95% CI 1.21 to 1.72), routine
home visits every three months by a specialist nurse (RR 1.46,
95% CI 1.23 to 1.74), and by routine doctor clinic appointments
every threemonths (RR 1.20, 95%CI 0.98 to 1.47), although this
third policy did not quite reach statistical significance (one trial,
318 participants, Analysis 3.2). Forty-three participants withdrew
from treatment; the reasons for their withdrawal and their group
allocation were not clear.
TB skin test reading
Four trials from the USA evaluated the effectiveness of pre-ap-
pointment reminders on return for tuberculin skin test read-
ing. Two evaluated take home reminder cards (Roberts 1983a;
Roberts 1983b), and three evaluated pre-appointment telephone
calls (Roberts 1983a; Tanke 1994; Cheng 1997).
Comparison 4: Reminder versus none
Compared to no reminders, there was little or no effect on at-
tendance for skin test reading for take home reminder cards (RR
0.96, 95% CI 0.88 to 1.02, two trials, 711 participants, Analysis
4.1), or for pre-appointment telephone calls (RR 1.06, 95% CI
0.92 to 1.21, three trials, 1189 participants, Analysis 4.1).
Comparison 5: Comparison of different reminders
In comparisons of different types of reminder, in Roberts 1983a
there were no statistically significant differences between take-
home cards, pre-appointment postcard reminders, or pre-appoint-
ment telephone reminders (one trial, 156 participants, Analysis
5.1).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
TB treatment: defaulter reminder versus no reminder
Patient or population: People on TB treatment
Settings: Outpatient clinic
Intervention: Default reminder
Comparison: No reminder
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
No reminder Defaulter reminder
Attendance at single clinic
appointment
10 per 100 52 per 100
(17 to 100)
RR 5.04
(1.61 to 15.78)
52
(1 trial)
⊕⊕©©
low1,2,3
Completion of TB treatment 78 per 100 91 per 100
(87 to 97)
RR 1.17
(1.11 to 1.24)
680
(2 trials)
⊕⊕⊕©
moderate4,5,6,7
The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1No serious risk of bias: This trial was at low risk of selection bias, but was unblinded.
2Downgraded by 1 for serious indirectness: This outcome was only reported from a single trial setting in India where DOTS was not
implemented and attendance at clinic was very low. The result may not be easily generalizable elsewhere.
3Downgraded by 1 for serious imprecision: This trial was underpowered to confidently detect clinically important effects.
4No serious risk of bias: Both trials were at low risk of selection bias.
5No serious inconsistency: This finding was consistent across trials.
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6Downgraded by 1 for serious indirectness: The two trials were conducted in Iraq and India and DOTS was only implemented in the Iraq
trial. One trial used home visits and one used reminder letters. The findings may not be easily generalized to all settings, and interventions
may need adapting to the local context.
7No serious imprecision: The trials are adequately powered to detect this effect.
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TB skin testing: pre-appointment reminder versus no reminder
Patient or population: People at risk of TB
Settings: Outpatient clinic
Intervention: Pre-appointment reminder
Comparison: No reminder
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
No reminder Pre-appointment reminder
Attendance at clinic 60 per 100 63 per 100
(55 to 72)
RR 1.06
(0.92 to 1.21)
1189
(3 trials)
⊕⊕©©
low1,2
The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the
relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded by 1 for serious risk of bias: Two trials are quasi-RCTs and at high risk of selection bias. The third provides few details of
randomization and is at unclear risk.
2Downgraded by 1 for serious indirectness: All three trials were conducted in the USA between 1983 and 1997, and the results may not
be easily generalized to elsewhere.
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D I S C U S S I O N
Summary of main results
We included nine trials, reported in eight papers, in this review.
Six trials assessed the use of pre-appointment reminders and three
assessed default reminders.
For people being treated for active TB, clinic attendance and TB
treatment completionwere higher in people receivingpre-appoint-
ment reminder phone-calls (low quality evidence). Clinic atten-
dance (low quality evidence) and TB treatment completion (mod-
erate quality evidence) were also higher with default reminders (let-
ters or home visits).
For people on TB prophylaxis, clinic attendance was higher with
a policy of pre-appointment phone-calls, and attendance at the
final clinic was higher with regular three-monthly phone-calls or
nurse visits.
For people undergoing screening for TB, three trials of pre-ap-
pointment reminder letters or phone-calls found little or no effect
on the proportion of people returning to clinic for the result of
their skin test (low quality evidence).
There is inadequate evidence to showdifferences between different
types of pre-appointment reminders (experts versus non-experts;
take-home card, a postcard or a telephone call) as well as between
different types of default reminders (home visit versus letter).
Overall completeness and applicability of
evidence
Almost all the included trials were conducted before or during the
1990s, when DOTS was not yet widely practised. Consequently,
some of the findings, especially those from settings where atten-
dance and treatment completion are very low, may be poorly ap-
plicable to settings where DOTS is being implemented and adher-
ence is much higher. However, two of the more recent trials were
conducted in areas with reasonable levels of treatment completion
(Mohan 2003; Kunawararak 2011) and still found clinically im-
portant gains through appointment reminders.
There is much interest and enthusiasm in the use of mobile phones
to improve patient adherence and attendance, but only one small
trial met our inclusion criteria. Mobile telephone use could be
used in various ways, for example, to remind patients to take their
medicine and keep appointments, to provide knowledge on TB,
and to support patients. There are quite a few pilot studies exam-
ining the use of mobile telephones in improving TB medication
adherence (Visarutrat 2009), but robust evidence on mobile tele-
phone reminders is still insufficient. Once completed, we may in-
clude a few ongoing trials evaluating SMS reminders in improving
TB adherence in future review updates although not all of them
may be relevant to our review (Bediang 2014).
It is important to note that we excluded studies that used bundled
interventions from this review (Thiam 2007). Excluding studies
that used packaged or multiple interventions implemented under
programme conditions limits the generalizability of this review.
This also highlights the difficulty of doing systematic reviews of
trials that test multiple or combined interventions to improve ad-
herence to long-term treatment regimens. Future reviews should
consider the implementation of interventions under programme
settings. Sustainability and duration of effectiveness of the inter-
ventions are other important factors to consider in assessing the ef-
fectiveness of healthcare interventions aimed at improving adher-
ence. Strategies to improve patient adherence can be divided into
patient-oriented, provider-oriented, and system interventions.
Quality of the evidence
We assessed the quality of evidence using the GRADE approach
and presented the findings in Summary of findings for the main
comparison, Summary of findings 2, and Summary of findings 3.
For people undergoing treatment for active TB, we judged the
quality of the evidence that pre-appointment reminder phone calls
improve clinic attendance and TB treatment completion to be of
low quality, meaning that further research is very likely to change
these estimates of effect. The main reasons for downgrading qual-
ity were: 1) risk of bias: none of the trials adequately described
methods to prevent selection bias; 2) indirectness: the single trial
assessing clinic attendance was from the USA and may be poorly
generalized to elsewhere; and 3) imprecision: the single trial re-
porting TB treatment completion was significantly underpowered
to confidently detect this effect.
We also considered the evidence that default reminders improve
clinic attendance to be of low quality because the single trial from
India was underpowered to detect clinical important effects and
the results are not be easily generalized to elsewhere. However, we
have more confidence that default reminders improve TB treat-
ment completion and judged this evidence to be of moderate qual-
ity. However, the evidence is still limited to just two trials im-
plementing different default reminder systems and further trials
would still be useful to improve confidence that the finding can
be generalized to elsewhere.
Potential biases in the review process
We minimized potential biases in the review process by adhering
to the guidelines of Higgins 2011.
Agreements and disagreements with other
studies or reviews
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A systematic review was published recently to assess the evidence
for the use of text messaging to promote adherence to TB treat-
ment, although the four studies included were not on reminder
systems for clinic appointments (Nglazi 2013). This review un-
derscored the paucity of high-quality studies on the effectiveness
of text messaging. Our review focused on interventions to remind
patients to take their medicine or keep appointments. Hence, we
also excluded a recent pilot study (Iribarren 2013) that assessed a
text messaging intervention to promote TB treatment adherence.
In this study, the SMS intervention was not to remind patients
about taking their medication or attend appointments but to re-
mind patients to text the investigators about their intake of med-
ications, to receive patients’ questions, and to send educational
texts.
A Cochrane Review of patient reminders and recall systems for
improving immunization rates showed that all types of reminders
were effective (postcards, letters, telephone, or autodialer calls),
with telephone being the most effective but most costly (Vann
2005). However, all trials were from high-income countries.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Policies of sending reminders to people pre-appointment, and con-
tacting people who miss appointments, seem like sensible addi-
tions to any TB program, and the limited evidence available sug-
gests they may have potentially important effects.
Different types of reminders canbe tailored to suit specific provider
and practice needs. Based on current studies, there is insufficient
evidence to assess the differences between different types of re-
minders. When choosing the type of reminders, some practical
issues also need to be considered, such as staffing, transportation,
health facilities, perceived accuracy of patient telephone numbers
or addresses, availability of computer programmers, overall pro-
gramme costs, and estimated patient responses to different types
of reminders. Practitioners need to consider their own settings
when interpreting the findings in this review since these factors
vary widely across nations or geographical regions.
Implications for research
Due to the poor quality of evidence, more well-designed trials are
needed to establish whether pre-appointment reminders are effec-
tive in different settings, and the best way of delivering reminders,
especially in low-income countries. For default reminders, more
high quality trials are needed to decide on the most effective
reminder actions in different settings. Specifically, future trials
should describe carefully the study design, setting, and the details
of the intervention, and report primary/clinical health outcomes
of the patients, as well as the resource implications. Future stud-
ies of modern technologies such as SMS reminders in addition to
DOT, or even in replacement of DOT, would be useful, particu-
larly for low-resource settings.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cheng 1997
Methods Trial design: Quasi-RCT
Participants Number of participants: 627 randomized
Inclusion criteria: consecutive children ages 1 to 12 years due for a TB test in an urban
children’s hospital outpatient department; 1 child per family enrolled
Exclusion criteria: not stated
Interventions All patients received a written information sheet with the times to return; skin tests were
circled in permanent marker and date of return stamped on mother’s and child’s hands
All families received education regarding the importance of skin testing for TB and the
need for follow-up to read the results. Instructions were given to return to the clinic in
48 to 72 hours
Intervention of interest:
• Reminder pre-appointment phone call 1 day before the appointment.
Control:
• Routine verbal and written instructions.
Other interventions not included in this review:
• Positive reinforcement group (transportation tokens and toy on return).
• Negative reinforcement group (asked to leave school forms until they returned for
test reading and were told that the test would be repeated if not read on time).
• Parents trained to read the Mantoux TB test for induration or no induration, and
a nurse home visit was scheduled to verify results.
Outcomes Outcomes included in this review:
• Adherence to return visit for Mantoux test reading.
Outcomes not included in this review :
• Reasons for poor adherence.
Notes Location: USA
Trial dates: not specified
Baseline data: comparable
Funding: Ambulatory Pediatrics Association
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomized by day of the week.
Allocation concealment (selection bias) High risk Sequential allocation.
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Cheng 1997 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 627/627 (100%), no missing data.
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported
in the results section
Other bias Low risk None identified.
Krishnaswami 1981
Methods Trial design: RCT
Participants Number of participants: 170 randomized; 150 analysed
Inclusion criteria: patients with symptoms reporting at the Institute of Tuberculosis and
Chest Diseases in Madras; with radiographic evidence of TB but negative smears; aged
≥ 12 years; prescribed national TB programme recommended regimen; living within a
radius of about 5 km from the clinic; bona fide residents of Madras city and regarded as
stable (expected to remain in the city for at least 1 year)
Exclusion criteria: not stated
Interventions Intervention of interest:
• Home visits 4 days after a missed appointment. If necessary, further visits were
made on the 11th day, and at 1 and 2 months. At one of the latter 2 visits, a doctor
accompanied the health visitor if the latter had met the patient at an early visit but had
failed to persuade the patient to attend.
• Reminder letter 4 days after a missed appointment - in Tamil (the local language).
If the patient still failed to attend, a health visitor went to the home on the 11th day to
see the patient personally and persuade him or her to attend.
Outcomes Outcomes included in this review:
• Treatment completion.
• Retrieval of the defaulters with the first action for the first episode of default.
Outcomes not included in this review:
• Retrieval of the defaulters with the first action for all episodes of default.
• Mean number of drug collections for one year.
• Number of episodes of default.
Notes Location: South India
Trial dates: not specified
Funding: Indian Council of Medical Research
Baseline data: comparable
Risk of bias
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Krishnaswami 1981 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only described as “randomised”.
Allocation concealment (selection bias) Unclear risk Only described as “randomised”.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 150/170 (89%); 20 participants excluded from main analysis
because of death (8), lost to follow-up (6), chemotherapy change
(3), or transfer to more accessible clinics (3), but missing out-
come data balanced in numbers across intervention groups, with
similar reasons for missing data across groups
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Kunawararak 2011
Methods Trial design: RCT
Participants Number of participants: 98 randomized
Inclusion criteria: patients aged > 15 years diagnosed with MTB who had never been
treated with second line TB drugs, patients in whom DST and HIV testing were per-
formed and whose liver function tests were lower than 2 times the upper limits of normal
Exclusion criteria: pregnant patients, MDR-TB patients resistant to 3 or more of 6
classes of second-line drugs, patients with history of epilepsy or alcoholism, patients who
could not answer questions by the researcher and patients who could not complete the
treatment
Interventions All patients had DOTS
Intervention of interest:
• Mobile phone call reminder to attend clinic appointments and take their
medication.
Control:
• No reminder.
Outcomes Outcomes included in this review:
• Treatment completion.
Outcomes not included in this review:
• Cure.
• Failure.
• Success.
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Kunawararak 2011 (Continued)
• Sputum conversion rate at 1 month.
Notes Location: Northern Thailand
Trial dates: April 2008 to December 2009
Baseline data: comparable
Funding: Graduate School of Chulalongkorn University, and the Department of Disease
Control, MInistry of Public Health, Thailand
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only described as “randomised”.
Allocation concealment (selection bias) Unclear risk Only described as “randomised”.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing data, 98/98 (100%).
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Mohan 2003
Methods Trial design: RCT
Participants Number of participants: 480 randomized
Inclusion criteria: new smear-positive PTB; never been treated previously; delayed com-
ing to collect drugs at the health centre for at least 3 days after scheduled appointment;
identified from official patient record cards
Exclusion criteria: re-treatment patients
Interventions Intervention of interest:
• Home visit by a local female volunteer from a local nongovernmental
organization who was trained to motivate patient to attend health centre daily and to
give health education (co-intervention) for the patient and his or her family.
Control:
• No home visit.
Outcomes Outcomes included in this review:
• Treatment completion.
Outcomes not included in this review:
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Mohan 2003 (Continued)
• Treatment interrupted for ≥ 2 consecutive months.
• Treatment failure: patient who is sputum positive at 5 months or later during
treatment.
• Death.
• Sputum smear positive follow-up.
Notes Location: Iraq
Trial dates: May 2001 to May 2002
Baseline data: not reported
Funding: the EMRO/DCD/TDR Small Grants Scheme for Operational Research in
Tropical and Communicable Diseases
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk By random-numbers table (confirmed by the trial authors).
Allocation concealment (selection bias) Low risk Using sequentially numbered and sealed opaque envelopes (con-
firmed by the trial authors)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The evaluation was blind as the information about outcome was
collected by a field worker who did not know which group the
patients were assigned to
Incomplete outcome data (attrition bias)
All outcomes
Low risk No missing data, 480/480 (100%).
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Paramasivan 1993
Methods Trial design: RCT
Participants Number of participants: 200 randomized
Inclusion criteria: newly diagnosed adult PTB patients; sputum positive for acid-fast
bacilli (AFB); no treatment or < 15 days previous treatment; not in moribund condition
or suffering from disorders like diabetes, cardiac failure, or renal failure; willing to stay
in the hospital for the initial 1-month intensive phase of treatment
Exclusion criteria: not stated
Interventions Intervention of interest:
• Defaulter reminder letter to the correct home address on the 4th day of the due
date. The second defaulter action became due only when the first action failed to
retrieve the patient, and it would be posted on the 8th day after the first action.
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Paramasivan 1993 (Continued)
Control:
• No reminder letter.
Outcomes Outcomes included in this review:
• Treatment completion.
Outcomes not included in this review:
• Treatment default: defined as number of patients failed to collect the drugs within
three days after the due date of drug collection.
• Defaulters retrieval: defined as number of defaulters retrieved.
Notes Location: South India
Trial dates: not specified
Baseline data: not reported
Funding: the Scientific Committee of Anti-tuberculosis Association of Tamilnadu
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random-numbers table (confirmed by the trial authors).
Allocation concealment (selection bias) Low risk Centralized randomization by a third party (confirmed by the
trial authors)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding of outcome assessment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 200/200 (100%), no missing data.
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Roberts 1983a
Methods Trial design: RCT
Participants Number of participants: 200 randomized
Inclusion criteria: volunteers who participated in a university-sponsored TB detection
drive; mostly college students
Exclusion criteria: not stated
Interventions Intervention of interest:
• Take-home reminder card.
• Postcard reminder.
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• Pre-appointment telephone call.
Control:
• Direct person-to-person reminder.
Outcomes Outcomes included in this review:
• Number of participants who return for skin-test reading.
Outcomes not included in this review : None.
Notes Location: USA
Trial dates: not specified
Baseline data: comparable
Funding: Research Grants Committee, University of Alabama
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only described as “randomised”.
Allocation concealment (selection bias) Unclear risk Only described as “randomised”.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 200/200 (100%), no missing data.
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Roberts 1983b
Methods Trial design: RCT
Participants Number of participants: 553 randomized
Inclusion criteria: volunteers who participated in a university-sponsored TB detection
drive
Exclusion criteria: not stated
Interventions Intervention of interest:
• Take-home reminder card with or without enhanced message on the importance
of returning, and with or without three types of overt commitment to return.
Control:
• No reminder card.
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Roberts 1983b (Continued)
Outcomes Outcomes included in this review:
• Number of participants who return for skin-test reading.
Outcomes not included in this review : None.
Notes Location: USA
Trial dates: not specified
Baseline data: comparable
Funding: Research Grants Committee, University of Alabama
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only described as “randomised”.
Allocation concealment (selection bias) Unclear risk Only described as “randomised”.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 553/553 (100%), no missing data.
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Salleras Sanmarti 1993
Methods Trial design: RCT
Participants Number of participants: 318 randomized
Inclusion criteria: school children of both sexes in the first year of primary school in state-
run and private schools in the provinces of Barcelona, on anti-TB chemoprophylaxis
Exclusion criteria: children with active TB confirmed by medical examination and chest
x-ray
Interventions Intervention of interest:
• Phone call reminder: Childrens’ mothers were telephoned by a specialized nursing
personnel every 3 months who informed them of the advantages of chemoprophylaxis
for their child’s health and encouraged them to continue with this preventive measure.
• Home visit reminder: Specialized nurse went to the patient’s home every 3
months providing health education to the mother and child, encouraging them to
continue with the preventive therapy, and giving them the same information leaflets
given at the first visit.
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Salleras Sanmarti 1993 (Continued)
• Child was seen by the physician every 3 months at the TB Prevention and
Control Centre, providing health education and leaflets at each visit.
Control:
• No health education activity performed.
Outcomes Outcomes included in this review:
• Adherence to final appointment.
Outcomes not included in this review:
• Negative Eidus-Hamilton reaction.
Notes Location: Spain
Trial dates: academic year 1985 to 1986
Baseline data: not reported
Funding: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Only described as “randomised”.
Allocation concealment (selection bias) Unclear risk Only described as “randomised”.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 275/318 (86.5%); 43/318 (13.5%) withdrew from treatment,
but number withdrew from each group not stated, nor reasons
for missing data provided
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported in the
results section
Other bias Low risk None identified.
Tanke 1994
Methods Trial design: Quasi-RCT
Participants Number of participants: 2008 randomized
Inclusion criteria: patients with scheduled appointments in the Tuberculosis Control
Program of Santa Clara County Health Department over a period of 6 months
Exclusion criteria: not stated
Interventions Intervention of interest:
• Basic reminder: pre-recorded message (TeleMinder system) from the county
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Tanke 1994 (Continued)
health department; identified the patient by name, indicated that the patient had an
appointment the following day, and gave the address and phone number of the clinic
twice; message could be repeated by remaining on the line; message did not refer to TB.
• Basic reminder plus authority endorsement: identified the Public Health Nurse at
the Health Department as the source of the message.
• Basic reminder plus importance statement: following statement was inserted after
the basic information: “Coming to this appointment is important so that you and your
family will not become seriously ill.”
• Basic reminder plus importance statement plus authority endorsement.
Control:
• No message.
Appropriate recorded message was sent to patients between 18.00 and 21.00 the evening
before the scheduled appointment. The system allows a message to be left on answering
machines and to call back up to 5 times at half-hour intervals if patients’ lines were
busy or there was no answer after 8 rings. For households whose primary language was
English, Spanish, Vietnamese, or Tagalog, the message was sent in that language
Outcomes Outcomes included in this review:
• Attendance for a scheduled appointment: if a patient had > 1 appointment during
the course of the trial, only data from the first appointment were included.
Outcomes not included in this review :
• Patient attitudes toward automated reminders.
Notes Location: USA
Trial dates: not specified
Baseline data: not reported
Funding: SBIR grants #2 R44 AI31750-02 from the National Institute of Allergy and
Infectious Diseases and #1 R43 AG10659-01 from the National Institute on Aging
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Within each 5-week period each message variation was used
once on each weekday, different variations were used each
day of a given week by a computer-generated system
Allocation concealment (selection bias) High risk Sequential allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2008/2008 (100%), no missing data.
Selective reporting (reporting bias) Low risk All relevant outcomes in the methods section are reported
in the results section
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Tanke 1994 (Continued)
Other bias Low risk None identified.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ailinger 2010 Pre-experimental design with historical comparison, cultural intervention with no reminder
Akhtar 2011 Clinic DOT versus family DOT, did not mention the intervention of interest
Al-Hajjaj 2000 Case-control study design.
Alcaide Megías 1990 Intervention did not include reminders.
Alvarez Gordillo 2003 Intervention did not include reminders.
Atkins 2011 Enhanced Tuberculosis Adherence (ETA) model versus DOT, ETA is a complex intervention contains
treatment supporter visits but the results cannot be disaggregated
Barclay 2009 Report.
Bordley 2001 Most participants did not have need for screening, prophylaxis or treatment for TB, and results for the
individuals in these categories were not presented separately
Bronner 2012 A retrospective study using routinely collected data from the South African national database for TB surveil-
lance
Grant 2010 Description on community education and mobilization of a TB preventive programme, reminder is not a
main component of the integrated intervention package
Hovell 2003 Intervention did not include reminders.
Hsieh 2007 The study evaluated case management that includes in-hospital direct supervision plus a home visit on
discharge
Hunchangsith 2010 Conference research abstracts.
Hunchangsith 2012 Treatment outcomes from the mobile phone intervention were derived from a case study
Iribarren 2013 A pilot randomized trial evaluating the acceptance, feasibility and initial efficacy of a text messaging inter-
vention to support TB treatment adherence. The intervention was more of a notification system (by the
patient) of drug intake and an educational intervention rather than a reminder system
Jin 1993 Intervention did not include reminders.
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(Continued)
Krishna 2002 Review article.
Lin 2006 Cohort study design.
Morisky 1990 Intervention did not include reminders, except for those routinely provided and also applied to the control
group
Morisky 2001 Intervention did not include reminders.
Nyamathi 2007 Process of reminders not described and the main objective was to assess predictors of latent TB infection
completion by using structural equation modelling among homeless adults
Sanneh 2010 Cross-sectional study.
Tanke 1997 A RCT compared a pre-recorded telephone reminder message (TeleMinder system) twice with no reminder
message. It only reported the percentages of participants returned for skin test reading without the events
and numbers of each groups. We contacted with the authors but got no feedback
Thiam 2007 Reminders not adequately described or systematically applied
Tokzek 2012 Review article.
Yusuf 2011 Conference research abstracts.
Characteristics of ongoing studies [ordered by study ID]
CTRI/2011/07/001889
Trial name or title The development and evaluation of m-Health service in the control of tuberculosis (TB) in India - TIMTAM
trial
Methods Study design: randomized; sequentially numbered, sealed, opaque envelopes; participant and outcome as-
sessor blinded
Inclusion criteria:
1. Owns a mobile phone and can read text messages.
2. Person with confirmed TB ( smear, or culture, or both).
3. Person having both TB and HIV disease.
4. Should be able to sign an informed consent.
Exclusion criteria: Not able to sign the informed consent document.
Participants Target sample size: 500
Interventions DOTS Plus mHealth: Patients in arm A (DOTS plus m-Health) will receive three text (SMS) messages every
week for the duration of their treatment as a part of the trial. Patients will be provided with a card containing
contact details for a telephone help line (24-hour help line), with clear instructions that this can be used, free
of charge, when access to face to face consultation is not available and medical advice is required
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CTRI/2011/07/001889 (Continued)
Outcomes Primary:
1. Treatment adherence rates.
2. Timepoint: Baseline, 3, and 6 months.
Secondary:
1. Treatment completion and cure rates.
2. Treatment success rates.
3. Adverse drug reaction rates.
4. Stigma associated with TB (measured by a validated survey).
5. Patient satisfaction (measured by a validated survey).
6. Usage of the m-Health initiative.
Timepoint: Baseline, 3, and 6 months
Starting date Date of registration: 14 July 2011
Date of first enrolment: 1 September 2011
Last refreshed on: 3 February 2014
Recruitment status: Not yet recruiting
Contact information URL: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=2883
Dilip Mathai
IDTRC IV Floor SP Complex Ida
Scudder Road Vellore
Vellore, TAMIL NADU, 632004, India
Notes Study ID: CTRI/2011/07/001889
Register: ClinicalTrials.gov
Location: India
Source of funding: School of Public Health and Community Medicine University of New South Wales
ISRCTN46846388
Trial name or title Cluster randomized trial of using mobile text messaging and a medication monitor in tuberculosis (TB) case
management
Methods Study design: Cluster randomized non-blinded controlled trial
Inclusion criteria:
1. TB patients, smear-positive or smear-negative, recruited from the study clusters (county/district).
2. Willing to participate in the study.
3. Conscious without any mental disease.
4. Conscious without any visual, auditory, or language impairment.
5. At least 18 years old.
6. Patient or family member is able to read a SMS text messages and use medication monitor after
training.
Exclusion criteria:
1. Does not meet inclusion criteria.
2. Patients with TB pleurisy.
3. Patients with no sputum smear data at TB diagnosis.
37Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment (Review)
Copyright © 2014 The Authors. The Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
ISRCTN46846388 (Continued)
Participants Target sample size: 4176 participants (116 per cluster; 9 clusters per arm; 4 arms); age minimum: N/A; age
maximum: N/A; gender: N/A
Interventions 1. Mobile phone reminder.
2. Medication monitor.
3. Mobile phone and medication monitor.
Outcomes Primary:
1. The mean proportion of months a patient has at least 3 doses missed (this is based on pill count data
from the medication monitor box).
Secondary:
1. The mean proportion of months a patient has at least 7 doses missed.
2. The mean proportion of overall missed doses.
3. Proportion of patients defined as non-adherent (at least 10% of doses missed).
4. Proportion of patients defaulting during TB treatment.
5. Proportion of smear positive TB cases who become smear negative at 2 months.
6. The proportion of patients with treatment outcome of cure or completed treatment.
Starting date Date of registration: 21 July 2011
Last refreshed on: 20 January 2014
Date of first enrolment: 1 June 2011
Recruitment status: Completed/not recruiting
Contact information URL: http://isrctn.org/ISRCTN46846388
Shiwen Jiang
China Center for Disease Control and Prevention No. 155 Changbai Road Changping District 102206
Beijing China
Notes Study ID: ISRCTN46846388
Register: ISRCTN
Location: China
Source of funding: Bill and Melinda Gates Foundation (Grant ref: 51914)
NCT01471977
Trial name or title Interventions to promote adherence to tuberculosis treatment among patients attending basic medical unit
of Taluka Gambat, Pakistan
Methods Study design: Non-randomized, single group assignment, open label
Inclusion criteria:
1. Adult patient.
2. > 18 years.
3. Either sex.
4. Diagnosed to have TB through chest x ray or sputum microscopy.
5. Eligible to participate in the study.
Participants Target sample size: 1280 participants; age minimum: 18 years; age maximum: N/A; gender: both
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NCT01471977 (Continued)
Interventions Education, counselling, default tracers, quality of care
Outcomes Primary:
1. Proportion of patients completed treatment (time frame: 8 months).
2. Proportion of patients cured (time frame: 8 months).
3. Proportion of patients defaulted (time frame: 8 months).
4. Proportion of patients died (time frame: 8 months).
5. Proportion of patients transferred out (time frame: 8 months).
6. Proportion of patients with treatment failure (time frame: 8 months).
Starting date Date of registration: 4 November 2011
Date of first enrolment: January 2004
Last refreshed on: 17 October 2012
Recruitment status: Completed
Contact information URL: http://clinicaltrials.gov/show/NCT01471977
Nisar Sheikh
Gambat Institute of Medical Sciences
Notes Study ID: NCT01471977
Register: ClinicalTrials.gov
Location: Pakistan
Source of funding:Gambat Institute of Medical Sciences
NCT01549457
Trial name or title A randomized controlled trial to examine the effectiveness of use of mobile phones and text messaging to
improve adherence to treatment of latent TB
Methods Study design: Randomized, single group assignment, open label
Inclusion criteria:
1. Are initiating treatment for latent TB infection.
2. Are over the age of 18 years old.
3. Own a mobile phone or share access mobile phone access with a household member who consents to
participate.
4. Demonstrate sufficient ability to communicate via text messaging in English or have a family member
or friend that is able to provide translation and assistance with text messaging for the duration of the study.
Exclusion criteria:
1. Individuals under the age of 18.
2. Unable to adequately send and receive text messages for any reason.
3. Enrolled in another clinical trial that may assess or influence treatment adherence.
Participants Target sample size: 486 participants; age minimum: 19 years; age maximum: N/A; gender: both
Interventions Cell phone text messages
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Outcomes Primary:
1. Successful completion of LTBI treatment regimens (time frame: 4 or 9 months).
Starting date Date of registration: 6 March 2012
Last refreshed on: 10 February 2014
Date of first enrolment: April 2012
Recruitment status: Recruiting
Contact information URL: http://clinicaltrials.gov/show/NCT01549457
Dr. Richard Lester
BC Centre for Disease Control
Canada
Notes Study ID: NCT01549457
Register: ClinicalTrials.gov
Location: Canada
Source of funding: University of British Columbia
NCT01690754
Trial name or title Evaluating the effectiveness of interactive SMS reminders on TB drug compliance and treatment
Methods Study design: Randomized, parallel assignment, open label
Inclusion criteria:
1. New, smear-positive drug susceptible TB who have been on treatment for less than two weeks.
2. Access to a mobile phone (self-reported).
3. Intending to reside in Karachi for the duration of their treatment.
Exclusion criteria:
1. Patients who do not have regular access to a mobile phone.
2. Patients who have previously received TB treatment.
3. Patients who have another member in their household who is already a part of the study.
Participants Target sample size: 2200 participants; age minimum: 15 years; age maximum: N/A; gender: both
Interventions Interactive reminders
Outcomes Primary:
1. Sputum conversion (time frame: at 2, 5, and 6 or 7 months of treatment).
2. Treatment compliance (time frame: monthly visits for 6 to 8 months of treatment).
3. Treatment outcomes (time frame: after 6 to 8 months of treatment).
Secondary:
1. Physical fitness and mobility (time frame: monthly visits for 6 to 8 months of treatment).
2. Psychological Impacts (time frame: monthly visits for 6 to 8 months of treatment).
3. Treatment Compliance (time frame: monthly visits for 6 to 8 months of treatment).
Starting date Date of registration: 13 September 2012
Date of first enrolment: March 2011
Last refreshed on: 17 October 2012
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NCT01690754 (Continued)
Recruitment status: Recruiting
Contact information URL: http://clinicaltrials.gov/show/NCT01690754
Shama Mohammed
Interactive Research and Development
Notes Study ID: NCT01690754
Register: ClinicalTrials.gov
Location: Pakistan
Source of funding: Interactive Research and Development; Massachusetts Institute of Technology
NCT02082340
Trial name or title Innovative approach in tuberculosis care in Armenia
Methods Study design: Randomized, efficacy study, parallel assignment, open label
Inclusion criteria:
1. Diagnosis of drug-sensitive TB.
2. Age 18 years old and above.
3. Understanding and reading in Armenian.
4. Completion of the intensive treatment phase.
Exclusion criteria:
1. Involvement in the home-based TB treatment programme of the National TB Control Office.
Participants Target sample size: 400 participants; age minimum: 18 years; age maximum: N/A; gender: both
Interventions Self-administered drug intake strategy, TB knowledge and socio-psychological counselling session, SMS text
messages, phone calls, educational leaflet
Outcomes Primary:
1. TB treatment success rates (time frame: patients will be followed for the duration of ambulatory phase
of treatment, an expected average of 4 months).
Secondary:
1. Depression status of TB patients.
2. Family support towards TB patients.
3. Knowledge about TB infection.
4. Quality of life of TB patients.
5. Stigma level towards TB patients.
6. TB treatment adherence.
Time frame: At baseline, 1, and 3 months after starting the ambulatory phase of the treatment and upon
completion of the treatment (an expected average of 4 months after starting the ambulatory phase of the
treatment)
Starting date Date of registration: 4 March 2014
Date of first enrolment: March 2014
Last refreshed on: 31 March 2014
Recruitment status: Active, not recruiting
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NCT02082340 (Continued)
Contact information URL: http://clinicaltrials.gov/show/NCT02082340
Varduhi Petrosyan
American University of Armenia Fund
Notes Study ID: NCT02082340
Register: ClinicalTrials.gov
Location: Armenia
Source of funding: Grand Challenges Canada
PACTR201307000583416
Trial name or title Evaluation of therapeutic adherence support by SMS on the cure rate of tuberculosis: a protocol of a ran-
domized control study
Methods Study design: Randomized, parallel assignment
Inclusion criteria:
1. Must be new smear positive PTB.
2. To have at least 18 years (born before 1st January 1995).
3. The patient must know how to read French or English.
4. Have a mobile phone number for personal use.
5. Know how to open and read an SMS on his telephone.
6. Give his consent (signed on the informed consent form).
Exclusion criteria
1. Hospitalized or severely ill patient as identified by health staff.
Participants Target sample size: 260 participants; age minimum: 18 years; age maximum: 60 years; gender: both
Interventions SMS
Outcomes Primary:
1. The cure rate at 6 months in the groups.
Secondary:
1. The degree of satisfaction.
2. The rate of treatment adherence (regularity in the respect of prescriptions and the percentage of
prescribed doses taken).
3. Treatment failure.
Starting date Date of registration: 5 July 2013
Last refreshed on: 3 February 2014
Date of first enrolment: 21 February 2013
Recruitment status: Open to recruitment: actively recruiting participants
Contact information URL: http://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?dar=true&tNo=
PACTR201307000583416
Jean-Louis Abena
Programme, Ministry of Public Health, Cameroon
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Notes Study ID: PACTR201307000583416
Register: PACTR
Location: South Africa
Source of funding: Geneva University Hospital
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D A T A A N D A N A L Y S E S
Comparison 1. TB treatment: reminder versus none
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Attendance at single clinic
appointment
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Pre-appointment phone
call
1 615 Risk Ratio (M-H, Random, 95% CI) 1.32 [1.10, 1.59]
1.2 Defaulter reminder letter 1 52 Risk Ratio (M-H, Random, 95% CI) 5.04 [1.61, 15.78]
2 TB cure or treatment completion 3 778 Risk Ratio (M-H, Random, 95% CI) 1.17 [1.11, 1.23]
2.1 Pre-appointment phone
call
1 98 Risk Ratio (M-H, Random, 95% CI) 1.14 [1.02, 1.27]
2.2 Defaulter reminder letter
or home visit
2 680 Risk Ratio (M-H, Random, 95% CI) 1.17 [1.11, 1.24]
Comparison 2. TB treatment: comparison of different reminders
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Attendance at single clinic
appointment
1 121 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.87, 1.45]
2 TB cure or treatment completion 1 150 Risk Ratio (M-H, Fixed, 95% CI) 1.2 [0.95, 1.51]
Comparison 3. TB prophylaxis: reminder versus none
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Attendance at single clinic
appointment
1 536 Risk Ratio (M-H, Fixed, 95% CI) 1.30 [1.07, 1.59]
2 Attendance at final clinic
appointment
1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Routine phone call every
three months
1 157 Risk Ratio (M-H, Random, 95% CI) 1.44 [1.21, 1.72]
2.2 Routine nurse home visit
every three months
1 156 Risk Ratio (M-H, Random, 95% CI) 1.46 [1.23, 1.74]
2.3 Routine doctor clinic
every three months
1 159 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.98, 1.47]
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Comparison 4. Skin test reading: reminder versus none
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Attendance at single clinic
appointment
4 1900 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.92, 1.10]
1.1 Take home reminder card 2 711 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.88, 1.04]
1.2 Pre-appointment phone
call
3 1189 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.92, 1.21]
Comparison 5. Skin test reading: comparison of different reminders
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Attendance at single clinic
appointment
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Take-home card versus
postcard
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Take-home card versus
telephone call
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Postcard versus telephone
call
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 TB treatment: reminder versus none, Outcome 1 Attendance at single clinic
appointment.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 1 TB treatment: reminder versus none
Outcome: 1 Attendance at single clinic appointment
Study or subgroup Reminder policy No reminders Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Pre-appointment phone call
Tanke 1994 (1) 327/490 63/125 100.0 % 1.32 [ 1.10, 1.59 ]
Subtotal (95% CI) 490 125 100.0 % 1.32 [ 1.10, 1.59 ]
Total events: 327 (Reminder policy), 63 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 2.98 (P = 0.0029)
2 Defaulter reminder letter
Paramasivan 1993 (2) 12/23 3/29 100.0 % 5.04 [ 1.61, 15.78 ]
Subtotal (95% CI) 23 29 100.0 % 5.04 [ 1.61, 15.78 ]
Total events: 12 (Reminder policy), 3 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 2.78 (P = 0.0054)
Test for subgroup differences: Chi2 = 5.15, df = 1 (P = 0.02), I2 =81%
0.1 0.2 0.5 1 2 5 10
Favours control Favours reminder policy
(1) Tanke 1994: Pre-appointment phone call reminder to attend clinic. Unclear if DOTS was implemented.
(2) Paramasivan 1993: Reminder letter to people who missed appointments. Treatment was self-supervized.
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Analysis 1.2. Comparison 1 TB treatment: reminder versus none, Outcome 2 TB cure or treatment
completion.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 1 TB treatment: reminder versus none
Outcome: 2 TB cure or treatment completion
Study or subgroup Reminder policy No reminders Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Pre-appointment phone call
Kunawararak 2011 (1) 49/49 43/49 21.4 % 1.14 [ 1.02, 1.27 ]
Subtotal (95% CI) 49 49 21.4 % 1.14 [ 1.02, 1.27 ]
Total events: 49 (Reminder policy), 43 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 2.29 (P = 0.022)
2 Defaulter reminder letter or home visit
Mohan 2003 (2) 231/240 198/240 65.2 % 1.17 [ 1.10, 1.24 ]
Paramasivan 1993 (3) 88/100 73/100 13.5 % 1.21 [ 1.05, 1.39 ]
Subtotal (95% CI) 340 340 78.6 % 1.17 [ 1.11, 1.24 ]
Total events: 319 (Reminder policy), 271 (No reminders)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.19, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 5.43 (P < 0.00001)
Total (95% CI) 389 389 100.0 % 1.17 [ 1.11, 1.23 ]
Total events: 368 (Reminder policy), 314 (No reminders)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.45, df = 2 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 5.87 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.23, df = 1 (P = 0.63), I2 =0.0%
0.5 0.7 1 1.5 2
Favours control Favours reminder policy
(1) Kunawararak 2011: Reminder phone call one-day before appointments. All patients had DOTS.
(2) Mohan 2003: Home visit to people who missed appointment. All patients had DOTS.
(3) Paramasivan 1993: Reminder letter to people who missed appointments. Treatment was self-supervized.
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Analysis 2.1. Comparison 2 TB treatment: comparison of different reminders, Outcome 1 Attendance at
single clinic appointment.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 2 TB treatment: comparison of different reminders
Outcome: 1 Attendance at single clinic appointment
Study or subgroup Home visit Letter Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Krishnaswami 1981 (1) 40/57 40/64 100.0 % 1.12 [ 0.87, 1.45 ]
Total (95% CI) 57 64 100.0 % 1.12 [ 0.87, 1.45 ]
Total events: 40 (Home visit), 40 (Letter)
Heterogeneity: not applicable
Test for overall effect: Z = 0.89 (P = 0.37)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours letter Favours home visit
(1) Krishnaswami 1981: The reminder home visit or letter were conducted four days after a missed appointment. TB treatment was self supervised with monthly pick-up
of medication.
Analysis 2.2. Comparison 2 TB treatment: comparison of different reminders, Outcome 2 TB cure or
treatment completion.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 2 TB treatment: comparison of different reminders
Outcome: 2 TB cure or treatment completion
Study or subgroup Home visit Letter Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Krishnaswami 1981 (1) 54/75 45/75 100.0 % 1.20 [ 0.95, 1.51 ]
Total (95% CI) 75 75 100.0 % 1.20 [ 0.95, 1.51 ]
Total events: 54 (Home visit), 45 (Letter)
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours letter Favours home visit
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(1) Krishnaswami 1981: The reminder home visit or letter were conducted four days after a missed appointment. TB treatment was self supervised with monthly pick-up
of medication.
Analysis 3.1. Comparison 3 TB prophylaxis: reminder versus none, Outcome 1 Attendance at single clinic
appointment.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 3 TB prophylaxis: reminder versus none
Outcome: 1 Attendance at single clinic appointment
Study or subgroup Phone call reminder No reminders Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Tanke 1994 (1) 257/411 60/125 100.0 % 1.30 [ 1.07, 1.59 ]
Total (95% CI) 411 125 100.0 % 1.30 [ 1.07, 1.59 ]
Total events: 257 (Phone call reminder), 60 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 2.63 (P = 0.0086)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [no reminder] Favours [reminder]
(1) Pre-appointment phone call reminder for people on TB prophylaxis
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Analysis 3.2. Comparison 3 TB prophylaxis: reminder versus none, Outcome 2 Attendance at final clinic
appointment.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 3 TB prophylaxis: reminder versus none
Outcome: 2 Attendance at final clinic appointment
Study or subgroup Reminder policy No reminders Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Routine phone call every three months
Salleras Sanmarti 1993 75/80 50/77 100.0 % 1.44 [ 1.21, 1.72 ]
Subtotal (95% CI) 80 77 100.0 % 1.44 [ 1.21, 1.72 ]
Total events: 75 (Reminder policy), 50 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 4.15 (P = 0.000034)
2 Routine nurse home visit every three months
Salleras Sanmarti 1993 75/79 50/77 100.0 % 1.46 [ 1.23, 1.74 ]
Subtotal (95% CI) 79 77 100.0 % 1.46 [ 1.23, 1.74 ]
Total events: 75 (Reminder policy), 50 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 4.33 (P = 0.000015)
3 Routine doctor clinic every three months
Salleras Sanmarti 1993 64/82 50/77 100.0 % 1.20 [ 0.98, 1.47 ]
Subtotal (95% CI) 82 77 100.0 % 1.20 [ 0.98, 1.47 ]
Total events: 64 (Reminder policy), 50 (No reminders)
Heterogeneity: not applicable
Test for overall effect: Z = 1.80 (P = 0.072)
Test for subgroup differences: Chi2 = 2.52, df = 2 (P = 0.28), I2 =21%
0.1 0.2 0.5 1 2 5 10
Favours control Favours reminder policy
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Analysis 4.1. Comparison 4 Skin test reading: reminder versus none, Outcome 1 Attendance at single clinic
appointment.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 4 Skin test reading: reminder versus none
Outcome: 1 Attendance at single clinic appointment
Study or subgroup Reminder No reminder Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Take home reminder card
Roberts 1983a (1) 93/114 39/44 21.4 % 0.92 [ 0.80, 1.06 ]
Roberts 1983b (2) 197/278 198/275 27.3 % 0.98 [ 0.89, 1.09 ]
Subtotal (95% CI) 392 319 48.7 % 0.96 [ 0.88, 1.04 ]
Total events: 290 (Reminder), 237 (No reminder)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.64, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 0.96 (P = 0.34)
2 Pre-appointment phone call
Cheng 1997 (3) 88/125 70/121 14.3 % 1.22 [ 1.01, 1.47 ]
Roberts 1983a (4) 35/42 39/44 16.4 % 0.94 [ 0.79, 1.12 ]
Tanke 1994 (5) 371/651 112/206 20.6 % 1.05 [ 0.91, 1.21 ]
Subtotal (95% CI) 818 371 51.3 % 1.06 [ 0.92, 1.21 ]
Total events: 494 (Reminder), 221 (No reminder)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.12, df = 2 (P = 0.13); I2 =52%
Test for overall effect: Z = 0.78 (P = 0.43)
Total (95% CI) 1210 690 100.0 % 1.01 [ 0.92, 1.10 ]
Total events: 784 (Reminder), 458 (No reminder)
Heterogeneity: Tau2 = 0.00; Chi2 = 7.18, df = 4 (P = 0.13); I2 =44%
Test for overall effect: Z = 0.13 (P = 0.90)
Test for subgroup differences: Chi2 = 1.36, df = 1 (P = 0.24), I2 =27%
0.5 0.7 1 1.5 2
Favours control Favours reminder
(1) Roberts 1983i: A take home card with appointment time for skin test reading 48 hours later.
(2) Roberts 1983ii: A take home card with appointment time for skin test reading 48 hours later.
(3) Cheng 1997: Pre-appointment phone call reminder to attend for Mantoux test reading
(4) Roberts 1983i: Pre-appointment phone call reminder to attend for skin test reading.
(5) Tanke 1994: Pre-appointment phone call reminder to attend for mantoux test result.
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Analysis 5.1. Comparison 5 Skin test reading: comparison of different reminders, Outcome 1 Attendance at
single clinic appointment.
Review: Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment
Comparison: 5 Skin test reading: comparison of different reminders
Outcome: 1 Attendance at single clinic appointment
Study or subgroup Reminder 1 Reminder 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Take-home card versus postcard
Roberts 1983a 37/45 56/69 1.01 [ 0.85, 1.21 ]
2 Take-home card versus telephone call
Roberts 1983a 37/45 35/42 0.99 [ 0.81, 1.20 ]
3 Postcard versus telephone call
Roberts 1983a 56/69 35/42 0.97 [ 0.82, 1.16 ]
0.5 0.7 1 1.5 2
Favours reminder 2 Favours reminder 1
A D D I T I O N A L T A B L E S
Table 1. Detailed search strategies
Search set Cochrane SRa CENTRAL MEDLINE
b
EMBASEb LILACSb SCI-EX-
PANDED
& SSCI
CINAHL
1 tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis tuberculosis
2 adherence PATIENT
COMPLI-
ANCE
TUBER-
CULOSIS/
DRUG
THERAPY/
PREVEN-
TIONAND
CONTROL
TUBER-
CULOSIS
adherence adherence adherence
3 compliance PATIENT
DROP-
OUTS
PATIENT
COMPLI-
ANCE
PATIENT-
COMPLI-
ANCE
compliance compliance compliance
4 monitor* RE-
MINDER
SYSTEMS
PATIENT
DROP-
OUTS
medication
adherence
Monitor$ monitor* monitor*
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Table 1. Detailed search strategies (Continued)
5 reminder* TREAT-
MENT RE-
FUSAL
COOPER-
ATIVE BE-
HAVIOUR
RE-
MINDER-
SYSTEM
Reminder$ reminder* reminder*
6 phone or
SMS* or text
or messaging
DIRECTLY
OB-
SERVED
THERAPY
TREAT-
MENT RE-
FUSAL
TREAT-
MENT-
REFUSAL
phone
or SMS$ or
text or mes-
saging
non-
adherence
non-
adherence
7 2 or 3 or 4 or
5 or 6
medication
adherence
medication
adherence
DI-
RECTLY-
OB-
SERVED-
THERAPY
2 or 3 or 4 or
5 or 6
late patient
tracer
late patient
tracer
8 1 and 7 electronic
monitoring
RE-
MINDER
SYSTEMS
electronic
monitoring
1 and 7 phone or
SMS* or text
or messaging
phone or
SMS* or text
or messaging
9 - nonadher-
ence
electronic
monitoring
nonadher-
ence
- 2-8/OR 2-8/OR
10 - non-
adherence
nonadher-
ence
non-
adherence
- 1 AND 9 1 AND 9
11 - late patient
tracer
non-
adherence
late patient
tracer
- - -
12 - phone or
SMS* or text
or messaging
DIRECTLY
OB-
SERVED
THERAPY
phone or
SMS* or text
or messaging
- - -
13 - 2-12 late patient
tracer
1 or 2 - - -
14 - 1 AND 13 phone or
SMS* or text
or messaging
3-12/OR - - -
15 - - 1 or 2 13 and 14 - - -
16 - - 3-14/OR - - - -
17 - - 15 and 16 - - - -
aCochrane Infectious Diseases Group Specialized Register and the Cochrane Effective Practice and Organisation of Care Group
Specialized Register.
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bSearch terms used in combination with the search strategy for retrieving trials developed by The Cochrane Collaboration (Lefebvre
2011). For controlled “before and after” studies, we used the terms: “before and after”; time series analysis; cohort analysis; controlled
study. Upper case: MeSH or EMTREE heading; lower case: free text term.
Table 2. Summary of populations and interventions
Trial ID Country Age group TB status TB inter-
vention
Supervi-
sion of
treatment
Type of re-
minder
Timing of
reminder
Pre/post
appoint-
ment
Control
Roberts
1983b
USA Adults At risk of
TB
Test N/A Take home
reminder
card1
N/A N/A Verbal
statement
in clinic
Roberts
1983a
USA Adults At risk of
TB
Test N/A Take home
reminder
card2
N/A N/A Verbal
statement
in clinic
N/A Postcard 1 day Pre-ap-
pointment
Verbal
statement
in clinic
N/A Phone call 1 day Pre-ap-
pointment
Verbal
statement
in clinic
Tanke
1994
USA All At risk of
TB
Test N/A Phone call3 1 day Pre-ap-
pointment
No phone
call
Cheng
1997
USA Children At risk of
TB
Test N/A Phone call 1 day Pre-ap-
pointment
Take home
reminder
card
Salleras
Sanmarti
1993
Spain Children Asymp-
tomatic
Prophy-
laxis
Parents A rou-
tine phone
call every 3
months
N/A N/A One-off
advice to
take treat-
ment for
12 months
A rou-
tine nurse
home visit
every 3
months
N/A N/A One-off
advice to
take treat-
ment for
12 months
A rou-
tine doctor
clinic
appoint-
ment every
3 months
N/A N/A One-off
advice to
take treat-
ment for
12 months
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Table 2. Summary of populations and interventions (Continued)
Tanke
1994
USA All Asymp-
tomatic
Prophy-
laxis
Unclear Phone call3 1 day Pre-ap-
pointment
No phone
call
Tanke
1994
USA All Symp-
tomatic
Treatment Unclear Phone call3 1 day Pre-ap-
pointment
No phone
call
Ku-
nawararak
2011
Thailand > 15 years Symp-
tomatic
Treatment DOTS Phone call 1 day Pre-ap-
pointment
DOTS
alone
Mohan
2003
Iraq Not stated Symp-
tomatic
Treatment DOTS Home visit 3 days Post-ap-
pointment
DOTS
alone
Krish-
naswami
1981
India > 12 years Symp-
tomatic
Treatment Self-
monthly
pick-up of
meds
Home visit 4 days Post-ap-
pointment
Reminder
letter
Paramasi-
van
1993
India Adult Symp-
tomatic
Treatment Self-
monthly
pick-up of
meds
Reminder
card
3 days Post-ap-
pointment
No
reminder
card
1Roberts 1983b also evaluated the effects of three types of participant commitment to return (no commitment, verbal, verbal plus
written), and two types of verbal messaging on the importance of returning (enhanced versus standard).
2Roberts 1983aalso evaluated the effect of two types of verbal messaging on the importance of returning (expert versus non-expert).
3Tanke 1994 evaluated four different automated phone messages: basic message, message with authority, message with importance,
and message with authority and importance. No differences were seen between the different messages.
Table 3. Optimal information size calculations
Outcome Hypothesis Power α error Proportion in control
group
Proportion in inter-
vention group
Total sample size re-
quired
Attendance
at clinic appoint-
ment
Superiority 80% 5% 50% 75% 110
80% 90% 394
TB cure or treat-
ment
completion
Superiority 80% 5% 50% 75% 110
80% 90% 394
We performed calculations using http://www.sealedenvelope.com
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WH A T ’ S N E W
Last assessed as up-to-date: 29 August 2014.
Date Event Description
16 September 2014 New citation required but conclusions have not
changed
The review was updated throughout.
16 September 2014 New search has been performed We changed the primary outcomes and added ’Sum-
mary of findings’ tables; a new search was conducted
and new trials added
The review authorship changed.
C O N T R I B U T I O N S O F A U T H O R S
This review was designed in collaboration with all six authors. KA and MADL screened the search results; KA retrieved the full papers
which met the inclusion criteria. KA and QL assessed the eligibility of the retrieved papers, and MAL acted as third author for this
stage. MA and VMB assessed the risk of bias of the included trials and extracted the data from papers; QL acted as a third author for
this stage. QL wrote to trial authors for additional information, entered the data into Review Manager 5; QL and DS undertook the
analyses and interpreted the data in consultation with the other review authors. QL drafted the review and the other review authors
provided comments and helped to revise the review.
D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• Chongqing Medical University, China.
External sources
• Department for International Development (DFID), UK.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We amended the original protocol title ’Reminder systems and late patient tracers in the diagnosis and management of tuberculosis’.
After publication of the original review, we found that the term ’late patient tracers’ was unfamiliar to many readers, hence we used
’pre-appointment reminders’ instead of ’reminder systems’ to mean any action to remind patients before they take their medication
or attend their appointment; and ’default reminders’ instead of ’late patient tracers’ to mean similar interventions undertaken when
patients fail to keep an appointment. Consequently, we changed the title to ’Reminder systems to improve patient adherence to TB
clinic appointments for diagnosis and treatment’ and also amended the terminologies in the review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Reminder Systems; Patient Compliance; Randomized Controlled Trials as Topic; Tuberculosis, Pulmonary [∗diagnosis; drug therapy]
MeSH check words
Adult; Child; Humans
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